Search Results

Your search for Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH,Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH matches 2 pages

Showing 1 - 2

By Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH / November 25, 2022

The NordICC Trial: The Devil Is in the Details

Colorectal cancer ranks third among cancer deaths in both men and women in the United States, with an estimated 150,000 new cases and 52,000 deaths anticipated in 2022.1 Colorectal cancer rates have declined by approximately 2% per year from 2014 to 2018 in people older than age 50, which is...

colorectal cancer

By Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH / November 2022

The NordICC Trial: The Devil Is in the Details

Colorectal cancer ranks third among cancer deaths in both men and women in the United States, with an estimated 106,000 new cases and 52,000 deaths anticipated in 2022.1 Colorectal cancer rates have declined by approximately 2% per year from 2014 to 2018 in people over the age of 50 years, which is ...

Dec

Today In Oncology

Search Results

Your search for Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH,Rishi Surana, MD, PhD, and Kimmie Ng, MD, MPH matches 2 pages

The NordICC Trial: The Devil Is in the Details

The NordICC Trial: The Devil Is in the Details

Ramucirumab Paclitaxel as Switch Maintenance in Advanced HER2-Negative Gastric Gastroesophageal Junction Cancer

Evidence-Based Recommendations and Knowledge Gaps Regarding Cardio-Oncology

Pharmacokinetic Comparison of Aumolertinib Osimertinib Gefitinib and Their Major Metabolites in NSCLC

MRD-Guided Chemotherapy Intensification After Induction in Fit Older Patients With AML

Study May Illuminate Cause of Common Checkpoint Inhibitor Adverse Effect